2014
DOI: 10.5152/tjg.2014.0001
|View full text |Cite
|
Sign up to set email alerts
|

Management of cystic diseases of the pancreas

Abstract: Pancreatic cysts are challenging to the gastroenterologist. Detection rate is increasing and neither criteria for a definitive diagnosis, nor a validated surveillance strategy is available. Pancreatic endosonography with or without sampling is necessary in most of the cases. However this technique requires expertise and is not widely available. While some cysts have a malignant potential or already malign at the diagnosis, most are benign and remain so for decades. We are going to review the existing data on t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 67 publications
0
1
0
Order By: Relevance
“…Given the malignant potential of MCNs (10%–39%) and IPMNs (36%–100%), routine monitoring is mandatory [ 3 ]. However, there is no single criterion or follow-up model for mucinous PCLs [ 4 ]. We aimed to analyze the role of cyst fluid carcinoembryonic antigen (CEA) level in differentiating MCNs from IPMNs as well as low-risk (LR)- versus high-risk (HR)-IPMNs.…”
Section: Introductionmentioning
confidence: 99%
“…Given the malignant potential of MCNs (10%–39%) and IPMNs (36%–100%), routine monitoring is mandatory [ 3 ]. However, there is no single criterion or follow-up model for mucinous PCLs [ 4 ]. We aimed to analyze the role of cyst fluid carcinoembryonic antigen (CEA) level in differentiating MCNs from IPMNs as well as low-risk (LR)- versus high-risk (HR)-IPMNs.…”
Section: Introductionmentioning
confidence: 99%